Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miki Nakajima

Showing results (81-90 of 288) with videos related to

Pageof 29
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 13, 2015
Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterasesTatsuki Fukami, Motoki Kariya, Takaya Kurokawa, et al.
Drug Metabolism and Pharmacokinetics|December 25, 2004
Activities of cytochrome p450 enzymes in liver and kidney microsomes from systemic carnitine deficiency mice with a gene mutation of carnitine/organic cation transporterHiroshi Yamazaki, Hitomi Iketaki, Ayaka Shibata, et al.
Toxicology Letters|August 9, 2006
Dephosphorylation of ribosomal protein P0 in response to troglitazone-induced cytotoxicityRawiwan Maniratanachote, Keiichi Minami, Miki Katoh, et al.
Drug Metabolism and Pharmacokinetics|February 15, 2011
Interpretation of the effects of protein kinase C inhibitors on human UDP-glucuronosyltransferase 1A (UGT1A) proteins in celluloYuko Abe, Ryoichi Fujiwara, Shingo Oda, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 16, 2011
CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assayAtsushi Iwamura, Tatsuki Fukami, Hiroko Hosomi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2007
Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substratesRyoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2007
Stereoselective glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin by human UDP-glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: effects of UGT-UGT interactionsMiki Nakajima, Hiroyuki Yamanaka, Ryoichi Fujiwara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2012
Contributions of arylacetamide deacetylase and carboxylesterase 2 to flutamide hydrolysis in human liverYuki Kobayashi, Tatsuki Fukami, Mai Shimizu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 21, 2006
CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophyllineTatsuki Fukami, Miki Nakajima, Haruko Sakai, et al.
Chemical Research in Toxicology|February 13, 2008
Human cytochrome P450 2A13 efficiently metabolizes chemicals in air pollutants: naphthalene, styrene, and tolueneTatsuki Fukami, Miki Katoh, Hiroshi Yamazaki, et al.
Pageof 29

Showing results (81-90 of 288) with videos related to

Sort By:
Pageof 29
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 13, 2015
Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterasesTatsuki Fukami, Motoki Kariya, Takaya Kurokawa, et al.
Drug Metabolism and Pharmacokinetics|December 25, 2004
Activities of cytochrome p450 enzymes in liver and kidney microsomes from systemic carnitine deficiency mice with a gene mutation of carnitine/organic cation transporterHiroshi Yamazaki, Hitomi Iketaki, Ayaka Shibata, et al.
Toxicology Letters|August 9, 2006
Dephosphorylation of ribosomal protein P0 in response to troglitazone-induced cytotoxicityRawiwan Maniratanachote, Keiichi Minami, Miki Katoh, et al.
Drug Metabolism and Pharmacokinetics|February 15, 2011
Interpretation of the effects of protein kinase C inhibitors on human UDP-glucuronosyltransferase 1A (UGT1A) proteins in celluloYuko Abe, Ryoichi Fujiwara, Shingo Oda, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 16, 2011
CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assayAtsushi Iwamura, Tatsuki Fukami, Hiroko Hosomi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2007
Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substratesRyoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2007
Stereoselective glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin by human UDP-glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: effects of UGT-UGT interactionsMiki Nakajima, Hiroyuki Yamanaka, Ryoichi Fujiwara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2012
Contributions of arylacetamide deacetylase and carboxylesterase 2 to flutamide hydrolysis in human liverYuki Kobayashi, Tatsuki Fukami, Mai Shimizu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 21, 2006
CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophyllineTatsuki Fukami, Miki Nakajima, Haruko Sakai, et al.
Chemical Research in Toxicology|February 13, 2008
Human cytochrome P450 2A13 efficiently metabolizes chemicals in air pollutants: naphthalene, styrene, and tolueneTatsuki Fukami, Miki Katoh, Hiroshi Yamazaki, et al.
Pageof 29